Vial Material and Integrity Believe it or not, the vial itself plays a role
It depends on factors such as the individuals starting weight, the dosage prescribed, and how closely the individual follows their treatment plan
If the patient can tolerate it, the dose is escalated to 1.7 mg (Wegovy) or 2 mg weekly (Ozempic) for the next four weeks and up to a maximum of 2.4 mg once weekly (Wegovy) afterwards as a maintenance dose
Retatrutide is not approved in the UK and should only be used as part of an authorised clinical trial
Studi condotti in altri paesi restituiscono risultati analoghi
Ju YE, McLeland JS, Toedebusch CD, Xiong C, Fagan AM, Duntley SP, et al